X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Themis Medicare Ltd.
BSE CODE: 530199   |   NSE CODE: THEMISMED   |   ISIN CODE : INE083B01024   |   29-Apr-2024 Hrs IST
BSE NSE
Rs. 225.65
9.35 ( 4.32% )
 
Prev Close ( Rs.)
216.30
Open ( Rs.)
217.85
 
High ( Rs.)
230.00
Low ( Rs.)
217.85
 
Volume
7728
Week Avg.Volume
5911
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 225.20
8.8 ( 4.07% )
 
Prev Close ( Rs.)
216.40
Open ( Rs.)
219.50
 
High ( Rs.)
228.00
Low ( Rs.)
217.50
 
Volume
79312
Week Avg.Volume
47533
 
52 WK High-Low Range(Rs.)
132.6
263.85
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)47.04  66.91  28.97  17.32  -13.83  
   CEPS(Rs)5.84  7.72  3.83  2.63  -0.51  
   DPS(Rs)5.00  5.00  4.30  1.75  0.00  
   Book NAV/Share(Rs)306.17  264.39  201.81  172.86  155.48  
   Tax Rate(%)26.51  26.66  17.45  11.62  12.64  
Margin Ratios          
   Core EBITDA Margin(%)19.04  24.24  21.63  17.70  1.40  
   EBIT Margin(%)19.32  23.49  19.49  15.32  -1.47  
   Pre Tax Margin(%)16.63  21.27  13.98  8.93  -7.89  
   PAT Margin (%)12.22  15.60  11.54  7.89  -6.90  
   Cash Profit Margin (%)15.18  18.00  15.25  11.99  -2.56  
Performance Ratios          
   ROA(%)10.02  16.72  8.07  5.18  -4.38  
   ROE(%)16.49  28.72  15.47  10.55  -8.51  
   ROCE(%)19.68  31.27  16.98  12.77  -1.18  
   Asset Turnover(x)0.82  1.07  0.70  0.66  0.63  
   Sales/Fixed Asset(x)1.71  2.16  1.44  1.37  1.28  
   Working Capital/Sales(x)2.80  3.72  3.95  7.61  45.39  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.58  0.46  0.69  0.73  0.78  
   Receivable days126.86  82.73  143.05  159.42  140.65  
   Inventory Days66.84  55.18  89.19  97.41  102.03  
   Payable days130.58  87.29  164.75  227.21  202.46  
Valuation Parameters          
   PER(x)24.79  13.95  9.68  13.86  0.00  
   PCE(x)19.96  12.09  7.32  9.12  -57.68  
   Price/Book(x)3.81  3.53  1.39  1.39  1.91  
   Yield(%)0.43  0.54  1.53  0.73  0.00  
   EV/Net Sales(x)3.24  2.31  1.38  1.56  1.90  
   EV/Core EBITDA(x)14.52  8.91  5.94  8.04  66.59  
   EV/EBIT(x)16.74  9.82  7.07  10.19  -129.23  
   EV/CE(x)2.46  2.29  0.94  0.98  1.20  
   M Cap / Sales3.03  2.18  1.12  1.09  1.48  
Growth Ratio          
   Net Sales Growth(%)-10.21  71.07  14.43  9.49  -12.12  
   Core EBITDA Growth(%)-22.73  90.99  36.66  643.70  -81.64  
   EBIT Growth(%)-26.15  106.21  45.58  1238.56  -112.76  
   PAT Growth(%)-29.67  131.24  67.30  225.33  -236.59  
   EPS Growth(%)-29.69  130.95  67.29  225.23  -236.59  
Financial Stability Ratios          
   Total Debt/Equity(x)0.33  0.32  0.46  0.63  0.57  
   Current Ratio(x)1.85  1.86  1.46  1.17  1.03  
   Quick Ratio(x)1.39  1.37  1.00  0.85  0.68  
   Interest Cover(x)7.16  10.57  3.54  2.40  -0.23  
   Total Debt/Mcap(x)0.09  0.09  0.33  0.45  0.30